Elaine Sun
Vermögen: 561 602 $ am 30.09.2026
Vermögen: 561 602 $ am 30.09.2026
Elaine D. Sun bekleidet die Position des Chief Financial Officer & Senior Vice President bei Halozyme Therapeutics, Inc. Frau Sun ist auch im Vorstand von Cirius Therapeutics, Inc. In der Vergangenheit war Frau Sun Chief Financial & Strategy Officer bei Vaxcyte, Inc. und Managing Director bei Merrill Lynch & Co, Inc. sowie Managing Director bei Evercore Capital Partners. Sie erhielt einen Bachelor-Abschluss vom Wellesley College und einen MBA von der Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 135.981 ( 0,03 % ) | 561 602 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.03.2025 |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops CRISPR-based genetic medicines, diagnostics, genome-editing technologies for healthcare and life science applications | Finanzdirektor/CFO | 23.03.2022 |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Direktor/Vorstandsmitglied | 05.01.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Direktor/Vorstandsmitglied | 10.02.2026 |
| HALOZYME THERAPEUTICS, INC. | Finanzdirektor/CFO | 02.02.2022 |
| VAXCYTE, INC. | Finanzdirektor/CFO | 01.12.2019 |
Nobel Laureate Meetings Lindau
Nobel Laureate Meetings Lindau Miscellaneous Commercial ServicesCommercial Services Operate as an internationally renowned scientific forum and academic cultural foundation | Gründer | - |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Wellesley College
Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evercore Capital Partners
Evercore Capital Partners Investment ManagersFinance Evercore Capital invests in middle-market companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements. | Finance |
Nobel Laureate Meetings Lindau
Nobel Laureate Meetings Lindau Miscellaneous Commercial ServicesCommercial Services Operate as an internationally renowned scientific forum and academic cultural foundation | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Health Technology |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops CRISPR-based genetic medicines, diagnostics, genome-editing technologies for healthcare and life science applications | Commercial Services |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen